Melissa Weimer, DO, MCR, FASAM is an Associate Professor of Medicine and Public Health at Yale School of Medicine and Yale School of Public Health. She is the Medical Director of the Yale Addiction Medicine Consult Service at Yale New Haven Hospital and Associate Program Director for the Yale Addiction Medicine Fellowship program. She is board certified in Internal Medicine and Addiction Medicine. Dr. Weimer is a national expert in complex pain evaluation and treatment and hospital-based addiction treatment.
Roger Chou, MD, FACP is a Professor in the Department of Medicine at Oregon Health & Science University (OHSU) School of Medicine. Board certified in Internal Medicine, Dr. Chou’s research interests are systematic review methodology, meta-analysis, screening and preventive services, guideline development, and drug effectiveness. He has conducted systematic reviews in a number of areas, including chronic pain and musculoskeletal conditions, screening and prevention, diagnostic testing, prognosis, HIV, viral hepatitis, COVID-19, and others. He has conducted many reviews to inform recommendations from the US Preventive Services Task Force, co-authored CDC guidelines on opioids for pain, and served as Director of Clinical Guideline Development for the American Pain Society, the GRADE methodologist for numerous World Health Organization guidelines, Coordinating Editor for Cochrane Back and Neck and Senior Editor for Cochrane Musculoskeletal, and on the Board of Scientific Counselors for CDC’s National Center for Injury Prevention and Control. Dr. Chou is a PCSS mentor.
Kevin A. Sevarino, MD, PhD, earned his MD, CM at McGill Faculty of Medicine and PhD in molecular biology at the University of Connecticut Health Center. After an internship in Internal medicine, he trained in psychiatry in the dual clinical/basic research tract at the Yale University School of Medicine. He has been PI on NIH grants examining neurobiological mechanisms underlying cocaine dependence and is now a clinician-educator. He was Medical Director of the Newington Mental Health Care Firm, Connecticut VA Healthcare System from Dec. 2004 through Aug. 2017 and consulting psychiatrist to Gaylord Hospital, Wallingford from 1999 – 2009, and again 2017-2023. He now works as per diem psychiatrist at Hartford Healthcare – Rushford. His particular expertise is in treatment of the dually-diagnosed and non-opiate pharmacological management of chronic pain. He is Associate Clinical Professor of Psychiatry, Yale University School of Medicine, was subspecialty certified in Psychosomatic Medicine by the American Board of Psychiatry and Neurology from 2009 – 2019, in Addiction Medicine by the American Board of Addiction Medicine from 2010 – 2020, and currently in Addiction Medicine by the American Board of Preventative Medicine. Dr. Sevarino is Medical Director for the American Academy of Addiction Psychiatry (AAAP) and is a past president of that organization. He currently co-directs AAAP’s Advanced Addiction Psychopharmacology course.
Additional Expert Presenters:
Mark Bicket, MD, PhD, FASA
Daniel G. Tobin, MD, FACP
Sara Edmond, PhD
Laila Khalid, MD, MPH, and Michele Buonora, MD, MS, MHS
Katie Fitzgerald Jones PhD, ACHPN, CARN-AP
Christin Veasley, BS
Pat Bruckenthal, PhD, APRN-BC, FAAN
Kevin E. Vowles, PhD
Erin E. Krebs, MD, MPH
Elliot J. Krane, MD
Julie Childers, MD, FAAHPM, FASAM
